top of page

Knowledge Center

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Patient Stories

Advancing Targeted Cancer Therapy Selection Through Liquid Biopsy | Dr. Gilberto Lopes

Patient Stories

19 Dec 2025

Advancing Targeted Cancer Therapy Selection Through Liquid Biopsy | Dr. Gilberto Lopes

Read More
Advancing Targeted Cancer Therapy Selection Through Liquid Biopsy | Dr. Gilberto Lopes

Publications

Clinical utility of cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) next generation sequencing (NGS) for diagnosis and treatment of leptomeningeal metastasis (LM) in patients with non-small cell lung cancer (NSCLC): a multi-centre retrospective study

Publications

1 Dec 2025

Clinical utility of cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) next generation sequencing (NGS) for diagnosis and treatment of leptomeningeal metastasis (LM) in patients with non-small cell lung cancer (NSCLC): a multi-centre retrospective study

Read More
Clinical utility of cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) next generation sequencing (NGS) for diagnosis and treatment of leptomeningeal metastasis (LM) in patients with non-small cell lung cancer (NSCLC): a multi-centre retrospective study
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population

Publications

13 Nov 2025

High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population

Read More
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population
Predictive Model for Mortality Risk Stratification Using Laboratory Biomarkers in Singaporeans

Publications

12 Nov 2025

Predictive Model for Mortality Risk
Stratification Using Laboratory
Biomarkers in Singaporeans

Read More
Predictive Model for Mortality Risk Stratification Using Laboratory Biomarkers in Singaporeans

News & Updates

Lucence Launches CardioHemeRISK™ in the U.S. to Identify Early Risk Markers Associated with Heart Attack, Stroke, and Leukemia

News & Updates

12 Jan 2026

Lucence Launches CardioHemeRISK™ in the U.S. to Identify Early Risk Markers Associated with Heart Attack, Stroke, and Leukemia

Read More
Add
Lucence Demonstrates Combined ctDNA and ctRNA Liquid Biopsy Improves Diagnostic Yield at ASCO 2025

News & Updates

30 May 2025

Lucence Demonstrates Combined ctDNA and ctRNA Liquid Biopsy Improves Diagnostic Yield at ASCO 2025

Read More
Add
Agilus Diagnostics and Lucence Announce Strategic Collaboration to Advance Cancer Testing Services in India

News & Updates

24 Feb 2025

Agilus Diagnostics and Lucence Announce Strategic Collaboration to Advance Cancer Testing Services in India

Read More
Add

Webinars

The next generation of liquid biopsy testing

Webinars

12 Nov 2025

The next generation of liquid biopsy testing

The next generation of liquid biopsy testing
New Frontiers in Liquid Biopsy for Lung Cancer

Webinars

30 Jun 2021

New Frontiers in Liquid Biopsy for Lung Cancer

New Frontiers in Liquid Biopsy for Lung Cancer

Case Studies

LiquidHALLMARK® ctRNA Detects ALK Fusion in Lung Cancer

Case Studies

12 Nov 2025

LiquidHALLMARK® ctRNA Detects ALK Fusion in Lung Cancer

Read More
LiquidHALLMARK® ctRNA Detects ALK Fusion in Lung Cancer
bottom of page